These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1310398)

  • 1. Lysosome inhibitors enhance the ability of cyclic AMP-elevating agents to induce the LDL receptor in human vascular smooth muscle cells.
    Middleton B
    Biochem Biophys Res Commun; 1992 Jan; 182(2):830-5. PubMed ID: 1310398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic AMP stimulates the synthesis and function of the low-density lipoprotein receptor in human vascular smooth-muscle cells and fibroblasts.
    Middleton B; Middleton A
    Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):853-61. PubMed ID: 1313231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agents which increase cyclic AMP have diverse effects on low-density-lipoprotein-receptor function in human vascular smooth-muscle cells and skin fibroblasts.
    Middleton A; Middleton B
    Biochem J; 1990 May; 267(3):607-14. PubMed ID: 1692702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandins which elevate cyclic AMP increase low density lipoprotein receptor mRNA and activity in human extra-hepatic cells.
    Nield H; Middleton B
    Biochem Soc Trans; 1995 Feb; 23(1):5S. PubMed ID: 7758763
    [No Abstract]   [Full Text] [Related]  

  • 5. Lysosomal hydrolysis of lipids in a cell culture model of smooth muscle foam cells.
    Minor LK; Mahlberg FH; Jerome WG; Lewis JC; Rothblat GH; Glick JM
    Exp Mol Pathol; 1991 Apr; 54(2):159-71. PubMed ID: 2029936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prostaglandin E1, isoproterenol and forskolin on cyclic AMP levels and tension in rabbit aortic rings.
    Vegesna RV; Diamond J
    Life Sci; 1986 Jul; 39(4):303-11. PubMed ID: 3016438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chloroquine on the metabolism of phosphatidylcholine associated with low density lipoprotein in arterial smooth muscle cells.
    Ishikawa Y; Nishide T; Sasaki N; Shirai K; Saito Y; Yoshida S
    Atherosclerosis; 1989 Nov; 80(1):1-7. PubMed ID: 2604752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cyclic GMP elevation on isoprenaline-induced increase in cyclic AMP and relaxation in rat aortic smooth muscle: role of phosphodiesterase 3.
    Delpy E; Coste H; Gouville AC
    Br J Pharmacol; 1996 Oct; 119(3):471-8. PubMed ID: 8894166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic AMP-mediated control of LDL receptor gene expression in human skin fibroblasts.
    Holmes C; Middleton B
    Biochem Soc Trans; 1997 May; 25(2):179S. PubMed ID: 9191223
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of the use of the luciferase-reporter-gene system for gene-regulation studies involving cyclic AMP-elevating agents.
    Benzakour O; Kanthou C; Dennehy U; al Haq A; Berg LP; Kakkar VV; Cooper DN
    Biochem J; 1995 Jul; 309 ( Pt 2)(Pt 2):385-7. PubMed ID: 7626000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The vascular smooth muscle type I angiotensin II receptor mRNA is destabilized by cyclic AMP-elevating agents.
    Wang X; Nickenig G; Murphy TJ
    Mol Pharmacol; 1997 Nov; 52(5):781-7. PubMed ID: 9351968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of cyclic AMP in human skin fibroblasts results in increased capacity for HDL binding.
    Middleton A; Middleton B
    Biochim Biophys Acta; 1996 Jul; 1302(1):84-92. PubMed ID: 8695659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic AMP decreases LDL catabolism and cholesterol synthesis in the human hepatoma cell line HepG2.
    Maziere C; Maziere JC; Salmon S; Auclair M; Mora L; Moreau M; Polonovski J
    Biochem Biophys Res Commun; 1988 Oct; 156(1):424-31. PubMed ID: 2845980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandins and cyclic nucleotides. Modulators of arterial cholesterol metabolism.
    Hajjar DP
    Biochem Pharmacol; 1985 Feb; 34(3):295-300. PubMed ID: 2982384
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of forskolin to study the relationship between cyclic AMP formation and bone resorption in vitro.
    Lerner UH; Fredholm BB; Ransjö M
    Biochem J; 1986 Dec; 240(2):529-39. PubMed ID: 3028378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of cytoplasmic cholesteryl ester of smooth muscle cells in culture derived from rat, rabbit and bovine aorta.
    Stein O; Coetzee GA; Stein Y
    Biochim Biophys Acta; 1980 Dec; 620(3):538-49. PubMed ID: 7236657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The action of low density lipoprotein on vascular smooth muscle cells involves increase in intracellular pH.
    Koh E; Morimoto S; Nabata T; Miyashita Y; Kitano S; Morita R; Ogihara T
    Biochem Int; 1990; 20(1):127-33. PubMed ID: 2328017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity.
    Rose RJ; Liu H; Palmer D; Maurice DH
    Br J Pharmacol; 1997 Sep; 122(2):233-40. PubMed ID: 9313930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ammonium ion derived from bovine endothelial cells upon low density lipoprotein degradation in cultured vascular smooth muscle cells.
    Truskey GA; Davies PF
    Cell Biol Int Rep; 1985 Apr; 9(4):323-30. PubMed ID: 3995596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of hyaluronic acid synthase 2 (HAS2) in human vascular smooth muscle cells by vasodilatory prostaglandins.
    Sussmann M; Sarbia M; Meyer-Kirchrath J; Nüsing RM; Schrör K; Fischer JW
    Circ Res; 2004 Mar; 94(5):592-600. PubMed ID: 14752026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.